132 related articles for article (PubMed ID: 16902922)
1. The discovery of CCR5 receptor antagonists for the treatment of HIV infection: hit-to-lead studies.
Armour D; de Groot MJ; Edwards M; Perros M; Price DA; Stammen BL; Wood A
ChemMedChem; 2006 Jul; 1(7):706-9. PubMed ID: 16902922
[No Abstract] [Full Text] [Related]
2. 4,4-Disubstituted cyclohexylamine based CCR5 chemokine receptor antagonists as anti-HIV-1 agents.
Duan M; Aquino C; Dorsey GF; Ferris R; Kazmierski WM
Bioorg Med Chem Lett; 2009 Sep; 19(17):4988-92. PubMed ID: 19664920
[TBL] [Abstract][Full Text] [Related]
3. Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.
Miller JF; Turner EM; Gudmundsson KS; Jenkinson S; Spaltenstein A; Thomson M; Wheelan P
Bioorg Med Chem Lett; 2010 Apr; 20(7):2125-8. PubMed ID: 20207537
[TBL] [Abstract][Full Text] [Related]
4. 1-Amido-1-phenyl-3-piperidinylbutanes - CCR5 antagonists for the treatment of HIV. Part 1.
Barber CG; Blakemore DC; Chiva JY; Eastwood RL; Middleton DS; Paradowski KA
Bioorg Med Chem Lett; 2009 Feb; 19(4):1075-9. PubMed ID: 19171484
[TBL] [Abstract][Full Text] [Related]
5. CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives.
Wei RG; Arnaiz DO; Chou YL; Davey D; Dunning L; Lee W; Lu SF; Onuffer J; Ye B; Phillips G
Bioorg Med Chem Lett; 2007 Jan; 17(1):231-4. PubMed ID: 17081751
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1.
Tallant MD; Duan M; Freeman GA; Ferris RG; Edelstein MP; Kazmierski WM; Wheelan PJ
Bioorg Med Chem Lett; 2011 Mar; 21(5):1394-8. PubMed ID: 21292480
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel (S)-alpha-phenyl-gamma-amino butanamide containing CCR5 antagonists via functionality inversion approach.
Zhang HS; Feng DZ; Chen L; Long YQ
Bioorg Med Chem Lett; 2010 Apr; 20(7):2219-23. PubMed ID: 20207141
[TBL] [Abstract][Full Text] [Related]
8. The discovery of tropane-derived CCR5 receptor antagonists.
Armour DR; de Groot MJ; Price DA; Stammen BL; Wood A; Perros M; Burt C
Chem Biol Drug Des; 2006 Apr; 67(4):305-8. PubMed ID: 16629828
[TBL] [Abstract][Full Text] [Related]
9. [2-(4-Phenyl-4-piperidinyl)ethyl]amine based CCR5 antagonists: derivatizations at the N-terminal of the piperidine ring.
Duan M; Aquino C; Ferris R; Kazmierski WM; Kenakin T; Koble C; Wheelan P; Watson C; Youngman M
Bioorg Med Chem Lett; 2009 Mar; 19(6):1610-3. PubMed ID: 19233649
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a piperidine-4-carboxamide CCR5 antagonist (TAK-220) with highly potent Anti-HIV-1 activity.
Imamura S; Ichikawa T; Nishikawa Y; Kanzaki N; Takashima K; Niwa S; Iizawa Y; Baba M; Sugihara Y
J Med Chem; 2006 May; 49(9):2784-93. PubMed ID: 16640339
[TBL] [Abstract][Full Text] [Related]
11. Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents.
Li B; Jones ED; Zhou E; Chen L; Baylis DC; Yu S; Wang M; He X; Coates JA; Rhodes DI; Pei G; Deadman JJ; Xie X; Ma D
Bioorg Med Chem Lett; 2010 Sep; 20(17):5334-6. PubMed ID: 20674358
[TBL] [Abstract][Full Text] [Related]
12. Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists.
Ernst J; Dahl R; Lum C; Sebo L; Urban J; Miller SG; Lundström J
Bioorg Med Chem Lett; 2008 Feb; 18(4):1498-501. PubMed ID: 18194864
[TBL] [Abstract][Full Text] [Related]
13. CCR5 antagonists as anti-HIV-1 agents. Part 2: Synthesis and biological evaluation of N-[3-(4-benzylpiperidin-1-yl)propyl]-N,N'-diphenylureas.
Imamura S; Kurasawa O; Nara Y; Ichikawa T; Nishikawa Y; Iida T; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
Bioorg Med Chem; 2004 May; 12(9):2295-306. PubMed ID: 15080927
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane.
Shah SK; Chen N; Guthikonda RN; Mills SG; Malkowitz L; Springer MS; Gould SL; Demartino JA; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA; MacCoss M
Bioorg Med Chem Lett; 2005 Feb; 15(4):977-82. PubMed ID: 15686896
[TBL] [Abstract][Full Text] [Related]
15. CCR5 antagonists for the treatment of HIV.
Barber CG
Curr Opin Investig Drugs; 2004 Aug; 5(8):851-61. PubMed ID: 15600241
[TBL] [Abstract][Full Text] [Related]
16. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and biological evaluation of 5-(piperidin-1-yl)-3-phenyl-pentylsulfones as CCR5 antagonists.
Shankaran K; Donnelly KL; Shah SK; Caldwell CG; Chen P; Finke PE; Oates B; MacCoss M; Mills SG; DeMartino JA; Gould SL; Malkowitz L; Siciliano SJ; Springer MS; Kwei G; Carella A; Carver G; Danzeisen R; Hazuda D; Holmes K; Kessler J; Lineberger J; Miller MD; Emini EA; Schleif WA
Bioorg Med Chem Lett; 2004 Jul; 14(13):3589-93. PubMed ID: 15177481
[TBL] [Abstract][Full Text] [Related]
18. The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection.
Maeda K; Nakata H; Ogata H; Koh Y; Miyakawa T; Mitsuya H
Curr Opin Pharmacol; 2004 Oct; 4(5):447-52. PubMed ID: 15351348
[TBL] [Abstract][Full Text] [Related]
19. Discovery and development of small-molecule chemokine coreceptor CCR5 antagonists.
Palani A; Tagat JR
J Med Chem; 2006 May; 49(10):2851-7. PubMed ID: 16686527
[No Abstract] [Full Text] [Related]
20. Exploration of a new series of CCR5 antagonists: multi-dimensional optimization of a sub-series containing N-substituted pyrazoles.
Lemoine RC; Petersen AC; Setti L; Jekle A; Heilek G; deRosier A; Ji C; Berry P; Rotstein DM
Bioorg Med Chem Lett; 2010 Aug; 20(16):4753-6. PubMed ID: 20643548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
